Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Follicular Lymphoma(FL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01827605
What this trial is testing

A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

Who this might be right for
Relapsed Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 159
Early research (Phase 1)Study completedNCT04488354
What this trial is testing

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

Who this might be right for
Relapsed/Refractory B-cell LymphomasDiffuse Large B-Cell Lymphoma (DLBCL)Follicular Lymphoma (FL)+9 more
Calibr, a division of Scripps Research 16
Early research (Phase 1)Study completedNCT03297424
What this trial is testing

PLX2853 in Advanced Malignancies.

Who this might be right for
Small Cell Lung CancerUveal MelanomaOvarian Clear Cell Carcinoma+5 more
Opna Bio LLC 49
Not applicableActive Not RecruitingNCT06070961
What this trial is testing

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

Who this might be right for
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07360288
What this trial is testing

Efficacy and Safety of TC011 in Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
TICAROS Co., Ltd. 40
Testing effectiveness (Phase 2)UnknownNCT04324879
What this trial is testing

TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL)

Who this might be right for
Relapsed / Refractory Follicular Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 80
Large-scale testing (Phase 3)Looking for participantsNCT05929222
What this trial is testing

Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi

Who this might be right for
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 190
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06549335
What this trial is testing

Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)

Who this might be right for
Follicular Lymphoma
Ruijin Hospital 66
Early research (Phase 1)Active Not RecruitingNCT06014762
What this trial is testing

P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh-grade B-cell LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)+7 more
Poseida Therapeutics, Inc. 120
Early research (Phase 1)Ended earlyNCT05169489
What this trial is testing

BbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Regeneron Pharmaceuticals 15
Early research (Phase 1)Looking for participantsNCT07424833
What this trial is testing

APG-3288 in Relapsed/Refractory Blood Cancers

Who this might be right for
Relapsed/Refractory Hematological MalignanciesRelapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLLRelapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL; Including Richter Transformation)+4 more
Ascentage Pharma Group Inc.
Early research (Phase 1)Study completedNCT00930514
What this trial is testing

A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma

Who this might be right for
Lymphoma, Follicular
Hoffmann-La Roche 281
Large-scale testing (Phase 3)Not Yet RecruitingNCT07719855
What this trial is testing

A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Study of Orelabrutinib Combined With Obinutuzumab and Lenalidomide Versus Obinutuzumab Plus Chemotherapy for Treatment-Naive Follicular Lymphoma

Who this might be right for
Follicular Lymphoma ( FL)
Ruijin Hospital 652
Early research (Phase 1)Ended earlyNCT02914938
What this trial is testing

ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Follicular Lymphoma (FL)+4 more
MEI Pharma, Inc. 97
Not applicableLooking for participantsNCT05899621
What this trial is testing

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

Who this might be right for
Follicular Lymphoma
Ruijin Hospital 332
Large-scale testing (Phase 3)Study completedNCT02947347
What this trial is testing

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Pharmacyclics LLC. 445
Large-scale testing (Phase 3)Active Not RecruitingNCT05888493
What this trial is testing

A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
Novartis Pharmaceuticals 109
Early research (Phase 1)Active Not RecruitingNCT05934838
What this trial is testing

A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

Who this might be right for
Follicular LymphomaB-Cell LymphomaMantle Cell Lymphoma+1 more
Weill Medical College of Cornell University 15
Not applicableLooking for participantsNCT07154823
What this trial is testing

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukaemia (AML)Follicular Lymphoma ( FL)
Tempus AI 550
Testing effectiveness (Phase 2)Study completedNCT00394836
What this trial is testing

HuMax-CD20 i(Ofatumumab) n Follicular Lymphoma (FL) Patients Refractory to Rituximab

Who this might be right for
Lymphoma, Follicular
GlaxoSmithKline 116
Next Page
180